down arrow

Pharmaids Pharma

39
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE117D01018
  • NSEID:
  • BSEID: 524572
INR
66.70
-0.29 (-0.43%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 15.45 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pharmaids Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
Profit Before Tax
-15.00
-9.00
0.00
Adjustment
3.00
0.00
0.00
Changes In working Capital
1.00
5.00
0.00
Cash Flow after changes in Working Capital
-10.00
-4.00
0.00
Cash Flow from Operating Activities
-10.00
-4.00
0.00
Cash Flow from Investing Activities
-74.00
-4.00
0.00
Cash Flow from Financing Activities
77.00
21.00
0.00
Net Cash Inflow / Outflow
-7.00
12.00
0.00
Opening Cash & Cash Equivalents
12.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
4.00
12.00
0.00
Compare Cash Flow Results of Pharmaids Pharma
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-15.62
2399.36
-2,414.00
-100.65%
Adjustment
3.88
212.2
-209.00
-98.17%
Changes In working Capital
1.12
20.42
-19.00
-94.52%
Cash Flow after changes in Working Capital
-10.62
2631.98
-2,641.00
-100.40%
Cash Flow from Operating Activities
-10.62
2152.45
-2,162.00
-100.49%
Cash Flow from Investing Activities
-74.99
-2080.52
2,006.00
96.40%
Cash Flow from Financing Activities
77.66
5.27
72.00
1373.62%
Net Cash Inflow / Outflow
-7.95
77.19
-84.00
-110.30%
Opening Cash & Cash Equivalents
12.75
304.82
-292.00
-95.82%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
4.8
382.01
-378.00
-98.74%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is -164.18% vs -1,446.15% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-10.62
-4.02
-164.18%

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."